Page last updated: 2024-09-02

sr 95531 and sch 23390

sr 95531 has been researched along with sch 23390 in 1 studies

Compound Research Comparison

Studies
(sr 95531)
Trials
(sr 95531)
Recent Studies (post-2010)
(sr 95531)
Studies
(sch 23390)
Trials
(sch 23390)
Recent Studies (post-2010) (sch 23390)
61002098030585

Protein Interaction Comparison

ProteinTaxonomysr 95531 (IC50)sch 23390 (IC50)
D(2) dopamine receptorHomo sapiens (human)1.0405
DRattus norvegicus (Norway rat)0.001
D(1A) dopamine receptorHomo sapiens (human)0.0461
D(1B) dopamine receptorHomo sapiens (human)0.0011
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0006
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.3891

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leyrer-Jackson, JM; Thomas, MP1

Other Studies

1 other study(ies) available for sr 95531 and sch 23390

ArticleYear
Dopaminergic D1 receptor effects on commissural inputs targeting layer V pyramidal subtypes of the mouse medial prefrontal cortex.
    Physiological reports, 2019, Volume: 7, Issue:20

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Mice; Neural Pathways; Prefrontal Cortex; Pyramidal Cells; Pyridazines; Receptors, Dopamine D1

2019